rabbit anti human trem2 monoclonal nonspecific cell signalling (Cell Signaling Technology Inc)
Structured Review
Rabbit Anti Human Trem2 Monoclonal Nonspecific Cell Signalling, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+trem2/pm41699693-469-133-138
Average 86 stars, based on 1 article reviews
Images
Related Articles
Expressing:Article Title: Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration. Article Snippet: Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.. The following primary antibodies were used: anti-human TREM2 (Cat# Article Title: Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration Article Snippet: Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.. The following primary antibodies were used: Immunofluorescence:Article Title: Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration. Article Snippet: Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.. The following primary antibodies were used: anti-human TREM2 (Cat# Article Title: Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration Article Snippet: Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.. The following primary antibodies were used: Staining:Article Title: Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration. Article Snippet: Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.. The following primary antibodies were used: anti-human TREM2 (Cat# Article Title: Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration Article Snippet: Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.. The following primary antibodies were used: Labeling:Article Title: Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration. Article Snippet: Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.. The following primary antibodies were used: anti-human TREM2 (Cat# Article Title: Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration Article Snippet: Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.. The following primary antibodies were used: MANN-WHITNEY:Article Title: Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration. Article Snippet: Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.. The following primary antibodies were used: anti-human TREM2 (Cat# Article Title: Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration Article Snippet: Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.. The following primary antibodies were used: Produced:Article Title: Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration. Article Snippet: Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.. The following primary antibodies were used: anti-human TREM2 (Cat# Article Title: Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration Article Snippet: Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.. The following primary antibodies were used: Knock-In:Article Title: Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration. Article Snippet: Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.. The following primary antibodies were used: anti-human TREM2 (Cat# Article Title: Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration Article Snippet: Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.. The following primary antibodies were used: Two Tailed Test:Article Title: Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration. Article Snippet: Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.. The following primary antibodies were used: anti-human TREM2 (Cat# Article Title: Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration Article Snippet: Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.. The following primary antibodies were used: Western Blot:Article Title: Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration. Article Snippet: Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.. The following primary antibodies were used: anti-human TREM2 (Cat# Article Title: Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration Article Snippet: Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.. The following primary antibodies were used: Over Expression:Article Title: Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration. Article Snippet: Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.. The following primary antibodies were used: anti-human TREM2 (Cat# Article Title: Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration Article Snippet: Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.. The following primary antibodies were used: Marker:Article Title: Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration. Article Snippet: Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.. The following primary antibodies were used: anti-human TREM2 (Cat# Article Title: Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration Article Snippet: Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.. The following primary antibodies were used: Comparison:Article Title: Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration. Article Snippet: Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.. The following primary antibodies were used: anti-human TREM2 (Cat# Article Title: Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration Article Snippet: Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.. The following primary antibodies were used: Gene Expression:Article Title: Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration. Article Snippet: Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.. The following primary antibodies were used: anti-human TREM2 (Cat# Article Title: Enhancing TREM2 expression activates microglia and modestly mitigates tau pathology and neurodegeneration Article Snippet: Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.Immunoblots were visualized using the Bio-Rad ChemiDoc MP imaging system.. The following primary antibodies were used: |
